Macula Vision Systems
Irvine, United States· Est.
Macula provides AI‑powered, low‑cost computational microscopy that automates slide analysis for clinical labs.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Macula provides AI‑powered, low‑cost computational microscopy that automates slide analysis for clinical labs.
Technology Platform
Low‑cost sensor‑illumination array combined with AI‑driven image reconstruction and diagnostic analysis, delivering optical‑grade microscopy without precision optics.
Opportunities
Expanding into high‑volume reference labs and point‑of‑care markets, and adding assay‑specific AI modules to broaden clinical indications.
Risk Factors
Regulatory approval timelines for AI‑based diagnostics and competition from established digital pathology vendors could delay market penetration.
Competitive Landscape
Competitors rely on expensive optics or software add‑ons; Macula differentiates with a fully integrated, low‑cost hardware‑compute solution requiring minimal specialist staff.